2025–2029 Pentavalent Market Outlook: Regional Trends and Growth Forecast
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Pentavalent Sector?
The market size for pharmacovigilance and drug safety software has experienced swift expansion in the past few years. It is projected to increase from $2.26 billion in 2024 to $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. The substantial growth during the historical phase is due to the escalating demand for pharmacovigilance and drug safety software.
The market for pharmacovigilance and drug safety software is anticipated to expand quickly in the upcoming years, expected to soar to “$4.09 billion in 2029 with a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this anticipated growth during the predicted time include a rise in instances of adverse drug reactions, an expansion of pharmacovigilance on a global level, growing complexity in drug safety regulations, advances in the development of new drugs and therapies, and an increase in cases of adverse drug reactions (ADRs). The forecast period is expected to witness trends such as the integration of automation and AI, adoption of cloud-based solutions, technological innovation, advancements in technology and an increase in the digitisation of healthcare.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Forces Are Driving The Growth Of The Pentavalent Market?
The escalating occurrence of diphtheria is anticipated to positively impact the growth of the pentavalent market in the future. The bacterium known as Corynebacterium diphtheriae is responsible for the severe and highly infectious disease named Diphtheria. This condition can cause serious issues with eating and breathing, as well as potentially leading to skin ulcers. By administering a three-dose pentavalent vaccine regimen, children can be safeguarded against diphtheria diseases, hence, the growing occurrence of diphtheria has led to an increased need for pentavalent vaccines. For instance, in 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported an unusually high number of diphtheria cases across June and August 2022 through the International Health Regulations (IHR) reporting process. Out of seven nations, 144 cases of diphtheria were reported, with a significant proportion amongst asylum seekers. Of these 144 patients, 97 (69%) were clinically compatible, 44(31%) were confirmed to have toxigenic diphtheria by laboratory tests, and 3 (2%) were regarded as suspected cases. Hence, the growing occurrence of diphtheria is a significant driving force propelling the expansion of the pentavalent market.
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
What Trends Are Currently Influencing Growth In The Pentavalent Market?
Key players in the pharmacovigilance and drug safety software market are pioneering the use of cutting-edge technologies, such as cloud-based data lake platforms. These platforms play a significant role in enhancing patient safety, improving adverse event monitoring, and assuring regulatory compliance in both clinical trials and post-market observation of medicinal devices. Essentially, a cloud-based data lake platform is a flexible, centralized storage system that facilitates the storage, management, and analysis of massive quantities of structured and unstructured data. It allows real-time access to data and facilitates advanced analysis and AI/ML workloads. For instance, Thermo Fisher Scientific Inc., a notable biotechnology firm based in the United States, rolled out CorEvidence in December 2023. CorEvidence is a patented cloud-based data lake platform designed to boost pharmacovigilance procedures within clinical research records. The platform is geared towards streamlining case handling and safety data management, especially concerning post-authorization safety trials.
Which Companies Currently Dominate The Competitive Landscape In The Pentavalent Industry?
Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies
Which Geographic Regions Are Driving Demand In The Pentavalent Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
